Bio-Rad Laboratories, Inc.’s stock price soars to $328.75, marking a significant 2.94% increase

Bio-Rad Laboratories, Inc. (BIO)

328.75 USD +9.38 (+2.94%) Volume: 0.24M

Bio-Rad Laboratories, Inc.’s stock price is currently soaring at 328.75 USD, marking a significant trading session increase of +2.94%. With a trading volume of 0.24M and a year-to-date percentage change of +1.81%, BIO’s stock performance is making positive strides in the market.

Latest developments on Bio-Rad Laboratories, Inc.

Today, Bio-Rad Laboratories, Inc. saw fluctuations in its stock price following the release of its Q3 2024 earnings forecast of $2.14 per share by Zacks Research. Analysts at Wells Fargo & Company gave the company an equal weight rating, further impacting investor sentiment. The FY2024 earnings forecast for Bio-Rad Laboratories, Inc. was also issued by Zacks Research, adding to the mix of factors influencing the stock price movements today on the NYSE under the ticker symbol BIO.

Bio-Rad Laboratories, Inc. on Smartkarma

Analysts at Baptista Research have provided bullish coverage of Bio-Rad Laboratories A on Smartkarma. In their report titled “Bio-Rad Laboratories: A Strengthened Position in Digital PCR (ddPCR) and Diagnostics With Solid Presence In China! – Major Drivers,” they highlighted the company’s second-quarter performance in 2024. CEO Norman Schwartz noted that the quarter met revenue expectations and showed better-than-expected margin performance. Despite facing challenges in the biotech and biopharma sectors, the company revised its full-year 2024 financial outlook cautiously.

In another report by Baptista Research on Smartkarma titled “Bio-Rad Laboratories Inc.: Exciting New Product Launches Can Propel Their Revenue Growth? – Major Drivers,” analysts discussed the multinational firm’s first-quarter 2024 financial results. The report noted that the company’s performance fluctuations were influenced by macroeconomic and market trends in the biotech and biopharma segments, particularly in countries like China and Russia. Despite observing a decline in the Life Science Group, the results were in line with internal estimates.

A look at Bio-Rad Laboratories, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Bio-Rad Laboratories A has a positive long-term outlook. With high scores in value and momentum, the company is positioned well for growth and profitability. The company’s products and systems are designed to separate and analyze complex materials, which could lead to continued success in the life science research and clinical diagnostics industries.

Although Bio-Rad Laboratories A has a lower score in dividends and growth, its resilience score indicates that the company is able to withstand economic challenges and market fluctuations. Overall, Bio-Rad Laboratories A appears to be a strong player in the industry with a solid foundation for future success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma